Literature DB >> 1918004

Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein.

F Besnard1, M Brenner, Y Nakatani, R Chao, H J Purohit, E Freese.   

Abstract

The gfa gene encodes glial fibrillary acidic protein, an intermediate filament protein found almost exclusively in astrocytes. Transient transfection studies with a chloramphenicol acetyltransferase reporter gene were used to identify regions of the gfa gene responsible for its expression. Three regions, A, B, and D, were found to be important. The D region is located near the basal promoter, while A and B are next to each other about 1500 bp further upstream. The regions contain several sequences homologous to binding sites of known transcription factors, and in addition, each contains an identical novel 10-bp motif. The A, B, and D regions act in a cell-specific manner; when joined to the SV 40 early promoter, they enhance transcription in the glial cell line U251, but not in the nonglial cell line HepG2. Consistent with this observation, the DNase I footprint produced in these regions by nuclear extract from U251 cells differs from that produced by an extract from HepG2 cells. The B region appears to be the most active of the three, as by itself it stimulates strong cell-specific transcription, whereas addition of the other two regions has little effect. When the B region is at its normal distance from the basal promoter, deletion of D severely reduces transcription, but when B is placed near the promoter, D is unimportant. This suggests that the D region may function primarily to promote interactions that bring B close to the promoter.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918004

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

2.  Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.

Authors:  Stephanie A Furrer; Mathini S Mohanachandran; Sarah M Waldherr; Christopher Chang; Vincent A Damian; Bryce L Sopher; Gwenn A Garden; Albert R La Spada
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

3.  Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes.

Authors:  E H Radany; M Brenner; F Besnard; V Bigornia; J M Bishop; C F Deschepper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia.

Authors:  Lijun Xu; John F Emery; Yi-Bing Ouyang; Ludmila A Voloboueva; Rona G Giffard
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

5.  The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes.

Authors:  Sandeep K Singh; Katarzyna M Wilczynska; Adrian Grzybowski; Jessie Yester; Bahiya Osrah; Lauren Bryan; Sarah Wright; Irene Griswold-Prenner; Tomasz Kordula
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

6.  GFAP promoter directs lacZ expression specifically in a rat hepatic stellate cell line.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Chun-Yan Zhang; Lang Zhuo
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

7.  Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.

Authors:  Jinte Middeldorp; Willem Kamphuis; Jacqueline A Sluijs; Dalila Achoui; Cathalijn H C Leenaars; Matthijs G P Feenstra; Paula van Tijn; David F Fischer; Celia Berkers; Huib Ovaa; Roy A Quinlan; Elly M Hol
Journal:  FASEB J       Date:  2009-03-30       Impact factor: 5.191

Review 8.  Gene therapy approaches in the non-human primate model of Parkinson's disease.

Authors:  D Pignataro; D Sucunza; A J Rico; I G Dopeso-Reyes; E Roda; A I Rodríguez-Perez; J L Labandeira-Garcia; V Broccoli; S Kato; K Kobayashi; José L Lanciego
Journal:  J Neural Transm (Vienna)       Date:  2017-01-27       Impact factor: 3.575

9.  Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.

Authors:  Michael I Dorrell; Edith Aguilar; Ruth Jacobson; Oscar Yanes; Ray Gariano; John Heckenlively; Eyal Banin; G Anthony Ramirez; Mehdi Gasmi; Alan Bird; Gary Siuzdak; Martin Friedlander
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

10.  Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.

Authors:  Amy C Arnold; Atsushi Sakima; Detlev Ganten; Carlos M Ferrario; Debra I Diz
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.